Clinical Trials Directory

Trials / Completed

CompletedNCT01505218

Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography

Patient-controlled Propofol Sedation for Endoscopic Retrograde Cholangiopancreatography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
281 (actual)
Sponsor
University Hospital, Linkoeping · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Propofol sedation with opioids is used for endoscopic retrograde cholangiopancreatography (ERCP). Combination of sedatives and opioids is associated with increased morbidity/mortality. Delivery of only propofol using a patient-controlled delivery system (patient-controlled sedation, PCS) could be an alternative for this purpose. Comparative studies with PCS for ERCP are few. Therefore, the main objective of this randomized controlled trial was to compare propofol PCS to sedation managed by nurse anaesthetists during ERCP.

Conditions

Interventions

TypeNameDescription
DRUGPropofol sedation by nurse anaesthestistPropofol (10 mg/ml) is a short-acting, intravenously administered hypnotic agent used for light-moderate-deep sedation. Patient-controlled sedation: self-administration of propofol boluses of 5 mg with zero lock-out time. Administration time for the pump was 12 sec, equivalent to maximum delivery of 25 mg of propofol per minute. Propofol sedation by nurse anaesthetists:
DRUGPatient-controlled propofol sedationPropofol (10 mg/ml) is a short-acting, intravenously administered hypnotic agent used for light-moderate-deep sedation. Self-administration of propofol via patient-controlled sedation pump (CME T-34L PCA). No programmed lock-out period, no dose limit or background infusion. 5 mg propofol/effectuated demand from the patients. Capacity of the pump was 6 possible doses per minute. Before start of ERCP the patients were allowed to sedate themselves to a sense of heavy tiredness.

Timeline

Start date
2010-10-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-01-06
Last updated
2020-11-09

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01505218. Inclusion in this directory is not an endorsement.